Seagen Inc.
(NASDAQ GS: SGEN)
Rigrodsky Law, P.A. is investigating Seagen Inc. (“Seagen”) regarding possible breaches of fiduciary duties and other violations of law related to Seagen’s agreement to be acquired by Pfizer Inc. Under the terms of the agreement, Seagen’s shareholders will receive $229.00 in cash per share.